|
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine |
|
CHEBI:138361 |
|
2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine |
|
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,13E,15S)-11α,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C25H44NO10P/c1- 2- 3- 6- 9- 19(28) 12- 13- 22- 21(23(29) 16- 24(22) 30) 10- 7- 4- 5- 8- 11- 25(31) 36- 20(17- 27) 18- 35- 37(32,33) 34- 15- 14- 26/h4,7,12- 13,19- 22,24,27- 28,30H,2- 3,5- 6,8- 11,14- 18,26H2,1H3,(H,32,33) /b7- 4- ,13- 12+/t19- ,20+,21+,22+,24+/m0/s1 |
MDIBHDWHCLLWJU-FLOWIMSISA-N |
P(=O)(O)(OCCN)OC[C@@H](CO)OC(CCC/C=C\C[C@H]1C(C[C@H]([C@@H]1/C=C/[C@H](CCCCC)O)O)=O)=O |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 2-acyl-sn-glycero-3-phosphoethanolamine )
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via 2-acyl-sn-glycero-3-phosphoethanolamine )
|
|
View more via ChEBI Ontology
Outgoing
|
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
has functional parent
prostaglandin E2
(CHEBI:15551)
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
has role
human xenobiotic metabolite
(CHEBI:76967)
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
has role
mouse metabolite
(CHEBI:75771)
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
is a
2-acyl-sn-glycero-3-phosphoethanolamine
(CHEBI:28936)
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
is a
prostanoid
(CHEBI:26347)
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
is tautomer of
2-[(5Z,13E,15S)-11α,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:137581)
|
|
Incoming
|
2-[(5Z,13E,15S)-11α,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:137581)
is tautomer of
2- [(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oyl]- sn- glycero- 3- phosphoethanolamine
(CHEBI:138361)
|
(2R)- 1- {[(2- aminoethoxy)(hydroxy)phosphoryl]oxy}- 3- hydroxypropan- 2- yl (5Z,11α,13E,15S)- 11,15- dihydroxy- 9- oxoprosta- 5,13- dien- 1- oate
|
2- (9- oxo- 11R,15S- dihydroxy- 5Z,13E- prostadienoyl)- sn- glycero- 3- phosphoethanolamine
|
ChEBI
|
2-(prostaglandin E2)-LPE
|
ChEBI
|
2-(prostaglandin E2)-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
27642067
|
PubMed citation
|
Europe PMC
|
|